Intellectual Property India Publishes Patent Application for 'Protac Chimeric Compound, Preparation Method Therefor And Use Thereof' Filed by Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd.

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517065073 A) filed by Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd., Zhejiang, China, on July 8, for 'protac chimeric compound, preparation method therefor and use thereof.'

Inventor(s) include Zhang, Zhimin; Zhai, Wenqiang; Wu, Mengqiang; Wang, Feng; Chang, Yujie; Wang, Ling; Wang, Linli; and Liu, Dongzhou.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "A compound represented by general formula (I) or a pharmaceutically acceptable salt or a stereoisomer thereof, and a use thereof in treating diseases such as tumors, immunologic diseases, and inflammatory diseases, as well as a pharmaceutical preparation and a pharmaceutical composition of the compound, and a use thereof."

The patent application was internationally filed on Dec. 15, 2023, under International application No.PCT/CN2023/139101.

Disclaimer: Curated by HT Syndication.